Increased labor induction and women presenting with decreased or altered fetal movements - a population-based survey by Anna Akselsson (6659081)

“…The rate of induction increased with number of times a woman sought care, RR 1.3 for single presentation to 3.2 for five or more.…”

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

Apigenin decrease eosinophil infiltration in colonic tissues from HFD-mice. by Daniela Gentile (5089280)

Image_1_Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.tif by Tanja M. Müller (10026137)

“…</p>Conclusion<p>COVID-19 is associated with a decrease in circulating adaptive immune cells expressing the key gut homing marker α4β7 suggesting that these cells are preferentially recruited to extra-intestinal tissues independently of α4β7 or that the systemic immune response against SARS-CoV-2 is at least numerically dominated by extraintestinal, particularly pulmonary, immune cell priming.…”

Image_4_Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.tif by Tanja M. Müller (10026137)

“…</p>Conclusion<p>COVID-19 is associated with a decrease in circulating adaptive immune cells expressing the key gut homing marker α4β7 suggesting that these cells are preferentially recruited to extra-intestinal tissues independently of α4β7 or that the systemic immune response against SARS-CoV-2 is at least numerically dominated by extraintestinal, particularly pulmonary, immune cell priming.…”

Image_3_Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.tif by Tanja M. Müller (10026137)

“…</p>Conclusion<p>COVID-19 is associated with a decrease in circulating adaptive immune cells expressing the key gut homing marker α4β7 suggesting that these cells are preferentially recruited to extra-intestinal tissues independently of α4β7 or that the systemic immune response against SARS-CoV-2 is at least numerically dominated by extraintestinal, particularly pulmonary, immune cell priming.…”

Knockout of <i>PDLIM2</i> results in increased STAT2 upon interferon treatment, decreased association with ubiquitin and increased nuclear retention. by Michael A. Joyce (267535)

The GmNN1/FT2a-GmNFYA-C-GmENOD40 module regulates soybean nodulation. by Xinxin Li (281237)

Gypsum and lime increase soybean and maize yield and decrease drought stress by Renan Ricardo Zandoná (5863079)

“…Gypsum increases the Ca2+ levels, redistributes Mg2+ to the 10-20 cm and 20-40 cm depth layers and decreases the Al3+ contents in the 20-40 cm layer. …”

Image_2_Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells.tif by Kanako Iwasaki (16451151)

“…</p>Methods<p>In this study, we explored the direct role of IGF1R in β-cell function and senescence using two independent mouse models with decreased IGF1/IGF1R signaling: a) Ames Dwarf mice (Dwarf ^+/+), which lack growth hormone and therefore have reduced circulating levels of IGF1, and b) inducible β-cell-specific IGF1R knockdown (βIgf1rKD) mice.…”

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients by J.F.M. Marchini (6515189)

Decrease of dermal markers after <i>Wnt11</i> RNAi. by Gabriela Morosan-Puopolo (211008)

Supplementary Material for: Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis by Yao G.-Y. (4139125)

“…<b><i>Methods:</i></b> We searched the PubMed and Embase databases to identify randomized controlled trials that evaluated the effect of macrolide therapy (of at least 2 weeks) for COPD. …”

General patient characteristics. by Ekaterina A. Bryushkova (13360122)

Subjects:

Individual dynamics of blood parameters. by Ekaterina A. Bryushkova (13360122)

Subjects:

Baseline clinical characteristics of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

Changes in CRP and LDH levels over time. by Ekaterina A. Bryushkova (13360122)

Subjects:

Minimal dataset. by Ekaterina A. Bryushkova (13360122)

Subjects:

The outcome timepoints and the mortality level of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

HDAC inhibitor reduced the expression of SGLT1 and decreased glucose uptake. by Chia-Wei Chou (354261)